Carbohydrate recognition [[electronic resource] ] : biological problems, methods, and applications / / edited by Binghe Wang, Geert-Jan Boons |
Pubbl/distr/stampa | Hoboken, N.J., : Wiley, c2011 |
Descrizione fisica | 1 online resource (450 p.) |
Disciplina | 612/.01578 |
Altri autori (Persone) |
WangBinghe
BoonsGeert-Jan |
Collana | Wiley series in drug discovery and development |
Soggetto topico | Carbohydrates - Therapeutic use |
ISBN |
1-283-22788-6
9786613227881 1-118-01757-9 1-118-01758-7 1-118-01756-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
CARBOHYDRATE RECOGNITION; PREFACE; CONTRIBUTORS; 1 MAMMALIAN GLYCAN BIOSYNTHESIS: BUILDING A TEMPLATE FOR BIOLOGICAL RECOGNITION; 2 THE ROLES OF CARBOHYDRATE BINDING IN CELL ADHESION AND INFLAMMATION; 3 THE ROLE OF CARBOHYDRATES IN VIRAL INFECTIONS; 4 THE ROLE OF CARBOHYDRATES IN BACTERIAL INFECTIONS; 5 THE ROLES OF CARBOHYDRATE BINDING IN FERTILIZATION; 6 CARBOHYDRATE BIOMARKERS; 7 GALECTINS AND THEIR ROLE IN VARIOUS BIOLOGICAL PROCESSES; 8 GLYCOIMMUNOLOGY; 9 TOOLS FOR GLYCOMICS: GLYCAN AND LECTIN MICROARRAYS; 10 COMBINATORIAL BIOSYNTHESIS OF COMPLEX CARBOHYDRATES
11 MASS SPECTROMETRY IN CARBOHYDRATE SEQUENCING AND BINDING ANALYSIS12 SYNTHETIC LECTIN MIMICS ARTIFICIAL CARBOHYDRATE RECEPTORS; 13 LECTIN BINDING AND ITS STRUCTURAL BASIS; 14 MULTIVALENCY IN CARBOHYDRATE BINDING; 15 CARBOHYDRATE BINDING AGENTS: POTENTIAL THERAPEUTICS WITH MULTIPLE INHIBITORY ACTIONS AGAINST ENVELOPED VIRUSES; 16 INFORMATICS FOR GLYCOBIOLOGY AND GLYCOMICS; INDEX |
Record Nr. | UNINA-9910139614503321 |
Hoboken, N.J., : Wiley, c2011 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Carbohydrate recognition : biological problems, methods, and applications / / edited by Binghe Wang, Geert-Jan Boons |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Hoboken, N.J., : Wiley, c2011 |
Descrizione fisica | 1 online resource (450 p.) |
Disciplina | 612/.01578 |
Altri autori (Persone) |
WangBinghe
BoonsGeert-Jan |
Collana | Wiley series in drug discovery and development |
Soggetto topico | Carbohydrates - Therapeutic use |
ISBN |
1-283-22788-6
9786613227881 1-118-01757-9 1-118-01758-7 1-118-01756-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
CARBOHYDRATE RECOGNITION; PREFACE; CONTRIBUTORS; 1 MAMMALIAN GLYCAN BIOSYNTHESIS: BUILDING A TEMPLATE FOR BIOLOGICAL RECOGNITION; 2 THE ROLES OF CARBOHYDRATE BINDING IN CELL ADHESION AND INFLAMMATION; 3 THE ROLE OF CARBOHYDRATES IN VIRAL INFECTIONS; 4 THE ROLE OF CARBOHYDRATES IN BACTERIAL INFECTIONS; 5 THE ROLES OF CARBOHYDRATE BINDING IN FERTILIZATION; 6 CARBOHYDRATE BIOMARKERS; 7 GALECTINS AND THEIR ROLE IN VARIOUS BIOLOGICAL PROCESSES; 8 GLYCOIMMUNOLOGY; 9 TOOLS FOR GLYCOMICS: GLYCAN AND LECTIN MICROARRAYS; 10 COMBINATORIAL BIOSYNTHESIS OF COMPLEX CARBOHYDRATES
11 MASS SPECTROMETRY IN CARBOHYDRATE SEQUENCING AND BINDING ANALYSIS12 SYNTHETIC LECTIN MIMICS ARTIFICIAL CARBOHYDRATE RECEPTORS; 13 LECTIN BINDING AND ITS STRUCTURAL BASIS; 14 MULTIVALENCY IN CARBOHYDRATE BINDING; 15 CARBOHYDRATE BINDING AGENTS: POTENTIAL THERAPEUTICS WITH MULTIPLE INHIBITORY ACTIONS AGAINST ENVELOPED VIRUSES; 16 INFORMATICS FOR GLYCOBIOLOGY AND GLYCOMICS; INDEX |
Record Nr. | UNINA-9910815595203321 |
Hoboken, N.J., : Wiley, c2011 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Carbohydrate-based vaccines and immunotherapies [[electronic resource] /] / edited by Zhongwu Guo, Geert-Jan Boons |
Pubbl/distr/stampa | Hoboken, N.J. ; ; Oxford, [UK], : Wiley, c2009 |
Descrizione fisica | 1 online resource (436 p.) |
Disciplina |
616.07/9
616.079 |
Altri autori (Persone) |
GuoZhongwu
BoonsGeert-Jan |
Collana | Wiley series in drug discovery and development |
Soggetto topico |
Carbohydrates - Immunology
Vaccines Glycoconjugates - Immunology |
ISBN |
1-282-36851-6
9786612368516 0-470-47328-2 0-470-47327-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
CARBOHYDRATE-BASED VACCINES AND IMMUNOTHERAPIES; CONTENTS; Preface; Contributors; 1 Glycobiology and Immunology; 1.1 Introduction; 1.2 Glycobiology; 1.2.1 Glycosylation-Is It Worth the Cost?; 1.2.2 Glycan Biosynthesis-A Dauntingly Complex Process; 1.2.3 Glycoproteins; 1.2.4 Lipid-Based Glycans; 1.2.5 Polysaccharides: Glycosaminoglycans and Bacterial Capsular Components; 1.3 The Immune System; 1.3.1 Introductory Comments; 1.3.2 Overview of the Immune System; 1.3.3 Glycoimmunobiology; 1.3.4 Interplay between Glycosylation and Sugars: a Two-Way Street; 1.4 Carbohydrate Antigens
1.4.1 Carbohydrate Antigens in Humans1.4.2 Carbohydrates and Pathogens; 1.4.3 Carbohydrate-Based Vaccines; 1.4.4 Concluding Comments: Building on Success; Acknowledgment; References; 2 Preparation of Glycoconjugate Vaccines; 2.1 Introduction; 2.2 Capsular Polysaccharide-Protein Conjugates; 2.2.1 Haemophilus influenzae Type b; 2.2.2 Streptococcus pneumoniae; 2.2.3 Neisseria meningitidis; 2.2.4 Salmonella typhi Vi; 2.2.5 Group B Streptococcus; 2.2.6 Staphylococcus aureus Types 5 and 8; 2.3 Lipopolysaccharide (LPS) and Lipooligosaccharide (LOS) Conjugates; 2.3.1 Escherichia coli O157 2.3.2 Vibrio cholerae O1 and O1392.3.3 Shigella dysenteriae Type 1, sonnei and flexneri 2a; 2.3.4 Neisseria meningitidis and Nontypeable Haemophilus influenzae; 2.4 Total Synthetic Glycoconjugate Vaccines; References; 3 Adjuvants for Protein- and Carbohydrate-Based Vaccines; 3.1 Introduction; 3.2 Initiation and Stimulation of Adaptive Responses; 3.3 "Old" Adjuvants and Formulations; 3.3.1 Aluminum; 3.3.2 Emulsions; 3.3.3 Saponins, QS21, and ISCOMS; 3.3.4 Liposomes and Microparticles; 3.3.5 Antigen/Formulation Targeting; 3.3.6 Induction of CD8 CTLs with Soluble Antigens 3.4 Renaissance of Innate Immunity3.4.1 Toll-Like Receptors: Agonists and Roles; 3.4.2 Non-TLRs Innate Receptors; 3.4.3 Other Receptors Involved in Antigen Capture and Recognition; 3.5 From Basic Research to Practical Applications: Identification of New Adjuvants; 3.5.1 TLR Synthetic Agonists; 3.5.2 Combination of PRR Agonists; 3.6 Adjuvants for Carbohydrate-Based Vaccines; 3.6.1 Td and Ti B-Cell Responses; 3.6.2 Adjuvants for "Free" Polysaccharides (Ti Antigens); 3.6.3 Adjuvants for Glycoconjugate Vaccines (T-Dependent Antigens) 3.7 Combinations of Adjuvants: Preclinical and Clinical Developments3.8 Immunomodulation of Existing Responses: Adjuvants for Therapeutic Vaccines; 3.9 Take Another Route; 3.9.1 Adjuvants for Mucosal Immunization; 3.9.2 Epidermal or Intradermal Routes; 3.10 Practical Aspects of Adjuvant Development; 3.10.1 Regulatory Aspects; 3.10.2 Safety versus Efficacy: Risk-Benefit Ratio; 3.11 Preclinical Models Used in Adjuvant Development; 3.11.1 Animal Models; 3.11.2 In vitro Models; 3.12 Conclusions and Perspectives; Acknowledgment; References; 4 Carbohydrate-Based Antibacterial Vaccines 4.1 Introduction |
Record Nr. | UNINA-9910139986703321 |
Hoboken, N.J. ; ; Oxford, [UK], : Wiley, c2009 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Carbohydrate-based vaccines and immunotherapies / / edited by Zhongwu Guo, Geert-Jan Boons |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Hoboken, N.J. ; ; Oxford, [UK], : Wiley, c2009 |
Descrizione fisica | 1 online resource (436 p.) |
Disciplina |
616.07/9
616.079 |
Altri autori (Persone) |
GuoZhongwu
BoonsGeert-Jan |
Collana | Wiley series in drug discovery and development |
Soggetto topico |
Carbohydrates - Immunology
Vaccines Glycoconjugates - Immunology |
ISBN |
1-282-36851-6
9786612368516 0-470-47328-2 0-470-47327-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
CARBOHYDRATE-BASED VACCINES AND IMMUNOTHERAPIES; CONTENTS; Preface; Contributors; 1 Glycobiology and Immunology; 1.1 Introduction; 1.2 Glycobiology; 1.2.1 Glycosylation-Is It Worth the Cost?; 1.2.2 Glycan Biosynthesis-A Dauntingly Complex Process; 1.2.3 Glycoproteins; 1.2.4 Lipid-Based Glycans; 1.2.5 Polysaccharides: Glycosaminoglycans and Bacterial Capsular Components; 1.3 The Immune System; 1.3.1 Introductory Comments; 1.3.2 Overview of the Immune System; 1.3.3 Glycoimmunobiology; 1.3.4 Interplay between Glycosylation and Sugars: a Two-Way Street; 1.4 Carbohydrate Antigens
1.4.1 Carbohydrate Antigens in Humans1.4.2 Carbohydrates and Pathogens; 1.4.3 Carbohydrate-Based Vaccines; 1.4.4 Concluding Comments: Building on Success; Acknowledgment; References; 2 Preparation of Glycoconjugate Vaccines; 2.1 Introduction; 2.2 Capsular Polysaccharide-Protein Conjugates; 2.2.1 Haemophilus influenzae Type b; 2.2.2 Streptococcus pneumoniae; 2.2.3 Neisseria meningitidis; 2.2.4 Salmonella typhi Vi; 2.2.5 Group B Streptococcus; 2.2.6 Staphylococcus aureus Types 5 and 8; 2.3 Lipopolysaccharide (LPS) and Lipooligosaccharide (LOS) Conjugates; 2.3.1 Escherichia coli O157 2.3.2 Vibrio cholerae O1 and O1392.3.3 Shigella dysenteriae Type 1, sonnei and flexneri 2a; 2.3.4 Neisseria meningitidis and Nontypeable Haemophilus influenzae; 2.4 Total Synthetic Glycoconjugate Vaccines; References; 3 Adjuvants for Protein- and Carbohydrate-Based Vaccines; 3.1 Introduction; 3.2 Initiation and Stimulation of Adaptive Responses; 3.3 "Old" Adjuvants and Formulations; 3.3.1 Aluminum; 3.3.2 Emulsions; 3.3.3 Saponins, QS21, and ISCOMS; 3.3.4 Liposomes and Microparticles; 3.3.5 Antigen/Formulation Targeting; 3.3.6 Induction of CD8 CTLs with Soluble Antigens 3.4 Renaissance of Innate Immunity3.4.1 Toll-Like Receptors: Agonists and Roles; 3.4.2 Non-TLRs Innate Receptors; 3.4.3 Other Receptors Involved in Antigen Capture and Recognition; 3.5 From Basic Research to Practical Applications: Identification of New Adjuvants; 3.5.1 TLR Synthetic Agonists; 3.5.2 Combination of PRR Agonists; 3.6 Adjuvants for Carbohydrate-Based Vaccines; 3.6.1 Td and Ti B-Cell Responses; 3.6.2 Adjuvants for "Free" Polysaccharides (Ti Antigens); 3.6.3 Adjuvants for Glycoconjugate Vaccines (T-Dependent Antigens) 3.7 Combinations of Adjuvants: Preclinical and Clinical Developments3.8 Immunomodulation of Existing Responses: Adjuvants for Therapeutic Vaccines; 3.9 Take Another Route; 3.9.1 Adjuvants for Mucosal Immunization; 3.9.2 Epidermal or Intradermal Routes; 3.10 Practical Aspects of Adjuvant Development; 3.10.1 Regulatory Aspects; 3.10.2 Safety versus Efficacy: Risk-Benefit Ratio; 3.11 Preclinical Models Used in Adjuvant Development; 3.11.1 Animal Models; 3.11.2 In vitro Models; 3.12 Conclusions and Perspectives; Acknowledgment; References; 4 Carbohydrate-Based Antibacterial Vaccines 4.1 Introduction |
Record Nr. | UNINA-9910825792303321 |
Hoboken, N.J. ; ; Oxford, [UK], : Wiley, c2009 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|